Impact Factor 5.085 | CiteScore 5.4
More on impact ›

Editorial ARTICLE

Front. Immunol., 24 July 2019 | https://doi.org/10.3389/fimmu.2019.01714

Editorial: Functional Relevance of Tetraspanins in the Immune System

  • 1Department of Cell Biology and Immunology, Centro de Biología Molecular Severo Ochoa (CSIC-UAM), Madrid, Spain
  • 2Department of Immunology, Ophthalmology and Otorhinolaryngology (IO2), Faculty of Medicine, Universidad Complutense, Madrid, Spain
  • 3Instituto de Investigación Sanitaria Hospital 12 de Octubre (i+12), Madrid, Spain
  • 4Departamento de Biología Molecular, CBM-SO, UAM/IIS-IP, Madrid, Spain
  • 5Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, Netherlands

Tetraspanins, members of the superfamily of four-transmembrane proteins, are evolutionary highly conserved membrane proteins that function as membrane-organizers (13). Immune cells express thousands of different membrane proteins (including adhesion receptors, uptake receptors, major histocompatibility molecules, enzymes, cytokine receptors, and others) that all need to be correctly localized in time and space at the cell surface. Tetraspanins specifically interact in cis with various immune receptors by forming multimolecular complexes (tetraspanin-enriched microdomains, TEMs) that can initiate immune cell signaling (4, 5). Thereby, tetraspanins control fundamental immune cell functions, including adhesion, pathogen uptake, immunological synapse formation, and proliferation. Tetraspanin-deficiency in mouse models and patients results in different immunological defects (6). This Review Topic provides a timely overview of the biological importance of tetraspanin-induced membrane organization in the immune system and the latest insights in targeting tetraspanins as novel drugs for infectious disease and cancer.

Immune cells are the fastest migrating cells in our body that depend on tight cooperation of different adhesion molecules (integrins, selectins, immunoglobulin superfamily members) and chemokine receptors to patrol for pathogens and reach inflammatory sites. For integrins, it has been well-established that clustering (avidity) and conformational change (affinity) both underlie activation. Tetraspanins are well-defined interaction partners for integrins (2, 7) that control adhesion and migration of lymphocytes, dendritic cells (8), and neutrophils (9). Yeung et al. discuss the functional roles of tetraspanins in leukocytes and endothelial cells during transmigration from the circulation into tissues. Most tetraspanins (CD9, CD37, CD81, and CD151) promote lymphoid and myeloid cell adhesion and migration through functional interaction with β1 and β2 integrins. In this regard, CD9 regulates the adhesive capacity of integrin α5β1 by modulating its association with the membrane protease ADAM17 on the cell surface (Machado-Pineda et al.). CD9 is also required for myeloid cell migration in a murine colitis model shown by decreased neutrophil and macrophage infiltration in colonic tissue from CD9-deficient mice (Saiz et al.). In contrast, tetraspanin CD82 in dendritic cells reduces cell motility through regulation of cytoskeletal proteins (e.g., RhoA). It is not known whether CD82 directly interacts with Rho GTPases, in line with the identified interaction between CD81 and Rac1 (10), or alternatively that CD82 regulates the cytoskeleton via interacting with ezrin/radixin/moesin (ERM) proteins. Besides directly interacting with adhesion molecules, tetraspanins have been reported to control the activity of membrane metalloproteases that can induce cleavage of adhesion receptors. For example, CD9 inhibits the shedding activity of ADAM17 and thereby supports ALCAM-dependent adhesion in antigen-presenting cells as discussed by Reyes et al. In line with this, tetraspanins of the TspanC8 subgroup, containing eight cysteine residues in their large extracellular loops, are required for ADAM10 exit from the endoplasmic reticulum and trafficking to the cell surface or other membrane compartments (11, 12). ADAM10 is well characterized as the ligand-dependent activator of Notch proteins, and Mike Tomlinson and colleagues discuss how TspanC8 members (Tspan5, Tspan10, Tspan14, Tspan15, Tspan17, and Tspan33) may control ADAM10 activity on myeloid and lymphoid cells in a specific manner (Matthews et al.). The most highly expressed TspanC8 in human and mouse T cells is Tspan14, followed by Tspan5 and Tspan17. Since both Tspan14 and Tspan5 promote Notch signaling, it is hypothesized that ADAM10 will have a major role in thymocyte development. Human and mouse B cells express high levels of Tspan33 and Tspan14, respectively, which may regulate Notch2 signaling and/or shedding of other ADAM10 ligands, such as CD23 (the IgEεRII). Some of these questions can be addressed by investigating newly generated Tspan14 and Tspan5-knockout mice. The authors also propose that targeting individual TspanC8 members may provide a novel therapeutic approach for ADAM10-associated diseases (leukemia, asthma, atherosclerosis, and Alzheimer's disease) without the toxicity of global ADAM10 inhibition.

Tetraspanins on antigen-presenting cells control multiple different functions, including cell migration, pathogen uptake, MHC trafficking, immunological synapse formation and antigen-presentation as reviewed by the group of Saiz et al. In B cells, tetraspanins (CD37, CD53, CD81) are essential for B cell receptor signaling, antibody production and cytokine secretion (Zou et al.). Interestingly, CD37-deficiency leads to spontaneous B cell lymphoma formation in mice, and patients with CD37-deficient B cell lymphomas have inferior clinical outcome than patients with CD37-positive lymphomas (13).

The pathogenesis of different infectious diseases is also influenced by different tetraspanin proteins (14). Besides adhesion and signaling, tetraspanins have been related to different membrane fusion events. The group of Peter Monk has explored the role of different tetraspanin members in membrane fusion of monocytic cells in response to Mycobacterium tuberculosis infection (Champion et al.). Tetraspanins can also interfere with different stages of the virus replication cycle. Florin and Lang evaluate how viruses exploit TEMs for viral entrance into cells, and subsequent budding and egress. Some viruses use specific tetraspanins as receptors (for example CD151-HPV, CD81-HCV) and by compartmentalizing host entry factors. In addition, viral envelope proteins accumulate in TEMs during morphogenesis, and induce large assemblies of tetraspanins and viral transmembrane proteins to facilitate budding. For example, tetraspanins (CD9, CD63, CD81, CD82) can be incorporated into the enveloping membrane of virions, such as HIV, feline immunodeficiency virus, influenza or hepatitis A virus, indicating that TEMs directly stimulate virus budding and exit. New evidence shows that HIV-1 replication is stimulated by CD81 through its direct interaction with the deoxynucleoside triphosphate phosphohydrolase SAMHD1 (15). Suárez et al. elaborate on the mechanisms underlying tetraspanin regulation of HIV-1 replication, which may be exploited to develop tetraspanin-based therapeutics as a novel strategy to restrict HIV-1 infection.

Given the plethora of immune functions that are controlled by tetraspanins, it is maybe not surprising that tetraspanins are important in anti-tumor immune responses. Even though this field is rather unexplored, tetraspanins expressed by immune suppressive cells (such as regulatory T cells, myeloid-derived suppressor cells) can control immune responses within the tumor microenvironment as discussed by Schaper and van Spriel. In addition, tetraspanins have been shown to modulate cancer metastasis indirectly through exosomes, and by regulating cellular interactions in the immune system as reflected on by Vences-Catalán and Levy.

Taken together, although broad in function, the underlying mechanism by which different tetraspanins accomplish their function is highly similar. Through their lateral molecular interactions with immune receptors, enzymes and/or signaling proteins, tetraspanins are in charge of organizing the protein landscape at the plasma membrane of immune cells. Evidence is now accumulating that these protein interactions are dynamic and likely change upon cell activation. Future research should provide better insight into the (1) specificity versus redundancy of individual tetraspanins on immune cell function, and (2) molecular mechanisms underlying TEM formation and coupling to signaling transduction pathways. The potency of targeting tetraspanins is currently under investigations at the (pre-)clinical level as novel therapeutics for cancer, infectious diseases and auto-immunity disorders (16, 17).

Author Contributions

CC, MY-M, and AS have contributed to the writing of this editorial article. They are the three authors for correspondence of this editorial.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

AS is supported by a Netherlands Organization for Scientific Research Grant (NWO) Gravitation Programme 2013 grant (ICI-024.002.009), a Dutch Cancer Society grant (KUN2014-6845), and was awarded an European Research Council Consolidator Grant (Secret Surface, 724281). MY-M is supported by BIO2017-86500-R Research Grant from the Spanish Ministerio de Ciencia, Innovación y Universidades. CC is supported by SAF2016-77096-R Research Grant from the Spanish Ministerio de Ciencia, Innovación y Universidades.

References

1. Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol. (2005) 6:801–11. doi: 10.1038/nrm1736

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Charrin S, le Naour F, Silvie O, Milhiet P-EE, Boucheix C, Rubinstein E. Lateral organization of membrane proteins: tetraspanins spin their web. Biochem J. (2009) 420:133–54. doi: 10.1042/BJ20082422

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Van Deventer SJ, Dunlock VME, van Spriel AB. Molecular interactions shaping the tetraspanin web. Biochem Soc Trans. (2017) 45:741–50. doi: 10.1042/BST20160284

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Tarrant JM, Robb L, Van Spriel AB, Wright MD. Tetraspanins: molecular organisers of the leukocyte surface. Trends Immunol. (2003) 24:610–7. doi: 10.1016/j.it.2003.09.011

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Levy S, Shoham T. The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol. (2005) 5:136–48. doi: 10.1038/nri1548

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Miranti CK, Bergsma A, Van Spriel AB. Tetraspanins as master organizers of the plasma membrane. In: Camb Ai, Lidke DS, editors. Cell Membrane Nanodomains: From Biochemistry to Nanoscopy. Boca Raton, FL: Taylor & Francis (2014). p. 59–86.

Google Scholar

7. Berditchevski F. Complexes of tetraspanins with integrins: more than meets the eye. J Cell Sci. (2001) 114:4143–51.

PubMed Abstract | Google Scholar

8. Gartlan KH, Wee JL, Demaria MC, Nastovska R, Chang TM, Jones EL, et al. Tetraspanin CD37 contributes to the initiation of cellular immunity by promoting dendritic cell migration. Eur J Immunol. (2013) 43:1208–19. doi: 10.1002/eji.201242730

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Wee JL, Schulze KE, Jones EL, Yeung L, Cheng Q, Pereira CF, et al. Tetraspanin CD37 Regulates β2 Integrin-Mediated Adhesion and Migration in Neutrophils. J Immunol. (2015) 195:5770–9. doi: 10.4049/jimmunol.1402414

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Tejera E, Rocha-Perugini V, López-Martín S, Pérez-Hernández D, Bachir AI, Horwitz AR, et al. CD81 regulates cell migration through its association with Rac GTPase. Mol Biol Cell. (2013) 24:261–73. doi: 10.1091/mbc.E12-09-0642

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Dornier E, Coumailleau F, Ottavi JF, Moretti J, Boucheix C, Mauduit P, et al. Tspanc8 tetraspanins regulate ADAM10/Kuzbanian trafficking and promote Notch activation in flies and mammals. J Cell Biol. (2012) 199:481–96. doi: 10.1083/jcb.201201133

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Haining EJ, Yang J, Bailey RL, Khan K, Collier R, Tsai S, et al. The TspanC8 subgroup of tetraspanins interacts with a disintegrin and metalloprotease 10 (ADAM10) and regulates its maturation and cell surface expression. J Biol Chem. (2012) 287:39753–65. doi: 10.1074/jbc.M112.416503

PubMed Abstract | CrossRef Full Text | Google Scholar

13. De Winde CM, Veenbergen S, Young KH, Xu-Monette ZY, Wang XX, Xia Y, et al. Tetraspanin CD37 protects against the development of B cell lymphoma. J Clin Invest. (2016) 126:653–66. doi: 10.1172/JCI81041

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Van Spriel AB, Figdor CG. The role of tetraspanins in the pathogenesis of infectious diseases. Microbes Infect. (2010) 12:106–12. doi: 10.1016/j.micinf.2009.11.001

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Rocha-Perugini V, Suárez H, Álvarez S, López-Martín S, Lenzi GM, Vences-Catalán F, et al. CD81 association with SAMHD1 enhances HIV-1 reverse transcription by increasing dNTP levels. Nat Microbiol. (2017) 2:1513–22. doi: 10.1038/s41564-017-0019-0

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Hemler ME. Targeting of tetraspanin proteins — potential benefits and strategies. Nat Rev Drug Discov. (2008) 7:747–58. doi: 10.1038/nrd2659

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Beckwith KA, Byrd JC, Muthusamy N. Tetraspanins as therapeutic targets in hematological malignancy: A concise review. Front Physiol. (2015) 6:91. doi: 10.3389/fphys.2015.00091

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: tetraspanin, immune cell, infection, vaccine, cell membrane

Citation: Cabañas C, Yáñez-Mó M and van Spriel AB (2019) Editorial: Functional Relevance of Tetraspanins in the Immune System. Front. Immunol. 10:1714. doi: 10.3389/fimmu.2019.01714

Received: 07 June 2019; Accepted: 09 July 2019;
Published: 24 July 2019.

Edited and reviewed by: Florent Ginhoux, Singapore Immunology Network (A*STAR), Singapore

Copyright © 2019 Cabañas, Yáñez-Mó and van Spriel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Carlos Cabañas, ccabanas@cbm.csic.es; María Yáñez-Mó, maria.yannez@uam.es; Annemiek B. van Spriel, Annemiek.vanSpriel@radboudumc.nl